| Authors: |
Medina J; Medical Affairs Department, AstraZeneca Spain, C. del Puerto de Somport 21-23, Fuencarral-El Pardo, 28050, Madrid, Spain., Sánchez-Covisa J; Medical Affairs Department, AstraZeneca Spain, C. del Puerto de Somport 21-23, Fuencarral-El Pardo, 28050, Madrid, Spain., Nuevo J; Medical Affairs Department, AstraZeneca Spain, C. del Puerto de Somport 21-23, Fuencarral-El Pardo, 28050, Madrid, Spain., Galvez-Fernandez M; Medical Affairs Department, AstraZeneca Spain, C. del Puerto de Somport 21-23, Fuencarral-El Pardo, 28050, Madrid, Spain., García A; Medical Affairs Department, AstraZeneca Spain, C. del Puerto de Somport 21-23, Fuencarral-El Pardo, 28050, Madrid, Spain., Pimentel B; Medical Affairs Department, AstraZeneca Spain, C. del Puerto de Somport 21-23, Fuencarral-El Pardo, 28050, Madrid, Spain., Fitas E; Medical Affairs Department, AstraZeneca Spain, C. del Puerto de Somport 21-23, Fuencarral-El Pardo, 28050, Madrid, Spain., Fernández E; Innovation and Digital Strategy Department, AstraZeneca Spain, Madrid, Spain., Walton RN; Biopharmaceuticals Medical, Real World Science and Analytics, AstraZeneca, Mississauga, ON, Canada., Petrovska M; Biopharmaceuticals Medical, Real World Science and Analytics, AstraZeneca, Cambridge, UK., Pérez Domínguez A; Medical Affairs Department, AstraZeneca Spain, C. del Puerto de Somport 21-23, Fuencarral-El Pardo, 28050, Madrid, Spain. ana.f.perez.dominguez@gmail.com. |